Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Jon E. Arnason"'
Autor:
Anita G. Koshy, Haesook T. Kim, Jessica Liegel, Jon E. Arnason, Vincent T. Ho, Joseph H. Antin, Robin Joyce, Corey S. Cutler, Mahasweta Gooptu, Sarah Nikiforow, Emma K. Logan, Pavania Elavalakanar, Michele Narcis, Dina Stroopinsky, Zachary M. Avigan, Leora Boussi, Susan L Stephenson, Hassan El Banna, Poorva Bindal, Giulia Cheloni, David E. Avigan, Robert J. Soiffer, Jacalyn Rosenblatt
Publikováno v:
Blood.
Steroid-refractory chronic graft versus host disease (cGVHD) remains a significant cause of morbidity and mortality following allogeneic transplantation. Abatacept is a selective co-stimulation modulator, used for the treatment of rheumatologic disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ac116ab8d5407f1dc27bfb199c3bfa9
https://doi.org/10.1182/blood.2022019107
https://doi.org/10.1182/blood.2022019107
Autor:
Poorva Bindal, Pavania Elavalakanar, Caitlin A. Trottier, Laura E. Dodge, Emma K. Logan, David J. Sermer, Michael Leukam, Matthew J Weinstock, Robin M. Joyce, Jessica Liegel, Jacalyn Rosenblatt, David Avigan, Carolyn D. Alonso, Jon E. Arnason
Publikováno v:
Blood. 140:5238-5240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7188e6151b24d925558d9616ca0852c
https://doi.org/10.1182/blood-2022-167976
https://doi.org/10.1182/blood-2022-167976
Autor:
Jeremy S. Abramson, Scott R. Solomon, Jon E. Arnason, Patrick B. Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi, Stephan Mielke, Pim Mutsaers, Francisco Hernandez-Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew A. Lunning, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Manali Kamdar
Publikováno v:
Blood. 140:1581-1583
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01b8585158d9c3b6928f93a4cb8f9716
https://doi.org/10.1182/blood-2022-159702
https://doi.org/10.1182/blood-2022-159702
Autor:
Rajat Bannerji, Jon E Arnason, Ranjana H Advani, Jennifer R Brown, John N Allan, Stephen M Ansell, Jeffrey A Barnes, Susan M O'Brien, Julio C Chávez, Johannes Duell, Andreas Rosenwald, Jennifer L Crombie, Melanie Ufkin, Jingjin Li, Min Zhu, Srikanth R Ambati, Aafia Chaudhry, Israel Lowy, Max S Topp
Publikováno v:
The Lancet Haematology. 9:e327-e339
Odronextamab is a hinge-stabilised, fully human IgG4-based CD20 × CD3 bispecific antibody that binds CD3 on T cells and CD20 on B cells. We aimed to evaluate the safety and antitumour activity of odronextamab in patients with relapsed or refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c7cea0a7b2e4936015a8f286ba40f6
https://doi.org/10.1016/s2352-3026(22)00072-2
https://doi.org/10.1016/s2352-3026(22)00072-2
Autor:
Matthew S. Davids, Svitlana Tyekucheva, Vanessa Rai, David C. Fisher, James A. Lederer, Emily M. Thrash, Stacey M. Fernandes, Stephen P. Martindale, Alec Griffith, Jennifer R. Brown, Oreofe O. Odejide, Brandon Lee, Timothy Z. Lehmberg, Zixu Wang, Jon E. Arnason, Deepti Gadi, John-Hanson Machado, Philippe Armand, Alexander R. Vartanov
Publikováno v:
Leukemia. 36:723-732
Several PI3Kδ inhibitors are approved for the therapy of B cell malignancies, but their clinical use has been limited by unpredictable autoimmune toxicity. We have recently reported promising efficacy results in treating chronic lymphocytic leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb1b7abf44624c518d572011b6d869f8
https://doi.org/10.1038/s41375-021-01441-9
https://doi.org/10.1038/s41375-021-01441-9
Autor:
Austin I. Kim, Caron A. Jacobson, Zixu Wang, Ann S. LaCasce, Samantha Pazienza, Jessica Lowney, Jennifer R. Brown, Matthew S. Davids, Jennifer L. Crombie, Matthew Weinstock, David C. Fisher, Svitlana Tyekucheva, Jon E. Arnason, Philippe Armand, Josie Montegaard, Samuel Y. Ng, Benjamin L. Lampson, Victoria Patterson
Publikováno v:
The Lancet Oncology. 22:1391-1402
Both continuous therapy with acalabrutinib and fixed-duration therapy with venetoclax-obinutuzumab are effective for previously untreated chronic lymphocytic leukaemia. We hypothesised that frontline time-limited, minimal residual disease (MRD)-guide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8fbe0b0a6328ba157009a8ae5a8c103
https://doi.org/10.1016/s1470-2045(21)00455-1
https://doi.org/10.1016/s1470-2045(21)00455-1
Autor:
David Avigan, Erik J. Uhlmann, Hemant Varma, Kartik Sehgal, Jared T. Ahrendsen, Sasmit Sarangi, Jon E. Arnason
Publikováno v:
Journal of Hematology
Chimeric antigen receptor (CAR) T-cell therapy targeting cluster of differentiation (CD)19 has had a transformative impact on patient outcomes in a subset of patients with relapsed/refractory non-Hodgkin lymphoma. We present a patient with refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c0c4576faf05cca9c0af142b76d5b2
http://europepmc.org/articles/PMC8577592
http://europepmc.org/articles/PMC8577592
Publikováno v:
Leukemia & Lymphoma. 63:54-63
Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) treatments have been rapidly evolving for patients treated in later lines of therapy (LoT). Country-specific cancer registry data for the US and Western Europe (WE) were combined with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::035ef62c6874fc5942a64c36721e1563
https://doi.org/10.1080/10428194.2021.1975188
https://doi.org/10.1080/10428194.2021.1975188
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:EPR21-034
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4992eb8ef7fa650b49160f57fb7cea7
https://doi.org/10.6004/jnccn.2020.7742
https://doi.org/10.6004/jnccn.2020.7742
Autor:
Christine E. Ryan, Benjamin L. Lampson, Svitlana Tyekucheva, Liam R. Hackett, Yue Ren, Samantha J. Shupe, Stacey M. Fernandes, Jennifer L. Crombie, Samuel Ng, Austin I. Kim, Inhye E. Ahn, Matthew J Weinstock, Samantha Pazienza, Josie S. Montegaard, Victoria Patterson, Caron A. Jacobson, Ann S. LaCasce, Philippe Armand, David C. Fisher, Jon E. Arnason, Steve Lo, Adam Olszewski, Jennifer R. Brown, Matthew S. Davids
Publikováno v:
Blood. 140:837-838
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17c1ae310aa10e7be8af40923f889750
https://doi.org/10.1182/blood-2022-168003
https://doi.org/10.1182/blood-2022-168003